跳至主要内容
临床试验/NCT01268709
NCT01268709已完成2 期

Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome

Qom University of Medical Sciences1 个研究点 分布在 1 个国家开始时间: 2010年12月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
试验地点
1

研究概览

简要总结

The objective of this randomized triple blind controlled trial is to compare the effects of Doxepin and Nortriptyline on diarrhea predominant irritable bowel syndrome. In this stuy, 75 patients with IBS are randomly assigned to receive Doxepin , Nortriptyline or placebo, a tablet per day, orally, for two months. Abdominal pain, mucus in the stool, incomplete evacuation, and bloating are measured and compared between groups at the baseline and one and two month after the intervention.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

性别
All
接受健康志愿者

入选标准

  • Presence of diarrhea predominant irritable bowel syndrome according to ROME criteria

排除标准

  • Gastrointestinal bleeding
  • More than 5% weight loss in the last 6 months
  • Presence of any finding in favor of organic disorders in the lab tests or organic disorder in colonoscopy of high risk patients

研究组 & 干预措施

doxepin

Active Comparator

干预措施: Doxepin (Drug)

nortriptyline

Active Comparator

干预措施: Nortriptyline (Drug)

placebo

Placebo Comparator

干预措施: placebo (Drug)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验